SEC Form 4 · accession 0001193125-26-394731
Tyra Biosciences, Inc. · TYRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan Fuhrman
Officer — Chief Financial Officer
Period of report
Sep 15, 2026
Accepted (ET)
Sep 17, 2026 · 7:25 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001863127
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Sep 15, 2026 | A | 951 | $9.129 | A | 37,115 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.
- F2Includes restricted stock units.